Increase in Prostate Cancer Distant Metastases at Diagnosis in the United States
- PMID: 28033446
- PMCID: PMC5470389
- DOI: 10.1001/jamaoncol.2016.5465
Increase in Prostate Cancer Distant Metastases at Diagnosis in the United States
Erratum in
-
Error in Methods Section.JAMA Oncol. 2017 May 1;3(5):709. doi: 10.1001/jamaoncol.2017.0054. JAMA Oncol. 2017. PMID: 28152121 Free PMC article. No abstract available.
Abstract
This population-based study assesses the effect of the decline in prostate-specific antigen screening and incidence on prostate cancer presentation.
Conflict of interest statement
Figures
Comment in
-
Determining Penetration of Prostate-Specific Antigen Screening Recommendations.JAMA Oncol. 2017 May 1;3(5):707. doi: 10.1001/jamaoncol.2016.5978. JAMA Oncol. 2017. PMID: 28033437 No abstract available.
-
Prostate cancer: More metastases - incidence increased in the USA.Nat Rev Urol. 2017 Apr;14(4):198. doi: 10.1038/nrurol.2017.5. Epub 2017 Jan 17. Nat Rev Urol. 2017. PMID: 28094331 No abstract available.
-
Re: Increase in Prostate Cancer Distant Metastases at Diagnosis in the United States.J Urol. 2017 Jul;198(1):104-105. doi: 10.1016/j.juro.2017.04.041. Epub 2017 Apr 12. J Urol. 2017. PMID: 28618673 No abstract available.
References
-
- National Cancer Institute Surveillance, Epidemiology, and End Results program. http://seer.cancer.gov/. Accessed April 26, 2016.
-
- Schröder FH, Hugosson J, Roobol MJ, et al. ; ERSPC Investigators . Screening and prostate-cancer mortality in a randomized European study. N Engl J Med. 2009;360(13):1320-1328. - PubMed
-
- Moyer VA; U.S. Preventive Services Task Force . Screening for prostate cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2012;157(2):120-134. - PubMed
-
- Shoag JE, Mittal S, Hu JC. Reevaluating PSA testing rates in the PLCO Trial. N Engl J Med. 2016;374(18):1795-1796. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous